Phathom Pharmaceuticals Inc (PHAT)

4.84 +0.43 (+9.75%) USD  |  NASDAQ  |  Mar 17, 16:00
5.20 +0.36 (+7.44%) After-Hours: 06:12
More

Phathom Pharmaceuticals Max Drawdown (5Y): 90.22% for Feb. 28, 2025

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for PHAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Stryker Corp 43.80%
Axsome Therapeutics Inc 81.26%
NovaBay Pharmaceuticals Inc 99.98%
Palatin Technologies Inc 97.60%
Theriva Biologics Inc 99.81%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -42.96
Beta (5Y) 0.6354
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 74.78%
Historical Sharpe Ratio (5Y) -0.4529
Historical Sortino (5Y) -0.8142
Monthly Value at Risk (VaR) 5% (5Y Lookback) 32.55%